agilon health, Inc (AGL) insider trading
Every open-market stock purchase and sale by agilon health, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $352K over the last 12 months (5 buys).
- Last insider buy: Benjamin Shaker (C-suite exec), n/a, 7 months ago.
Last 12 months: insiders bought $352K (5 buys) and sold $0 (0 sales). Last close $90.99 on Oct 21, 2026.
Recent AGL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 16, 2026 | Timothy Gertsch (C-suite exec) | Sold (not open market) | $1.6K |
| Aug 1, 2026 | Denise Zamore (C-suite exec) | Sold (not open market) | $3.4K |
| Jul 1, 2026 | Jeffrey A. Schwaneke (CFO) | Sold (not open market) | $258K |
| Jun 2, 2026 | Sharad Mansukani (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Karen McLoughlin (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Ronald A Williams (Director) | Bought (not open market) | — |
| Jun 2, 2026 | John William Wulf (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Silvana Battaglia (Director) | Bought (not open market) | — |
| Jun 2, 2026 | Diana McKenzie (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Denise Zamore (C-suite exec) | Sold (not open market) | $44.9K |
| May 24, 2026 | Timothy Gertsch (C-suite exec) | Sold (not open market) | $691 |
| May 7, 2026 | Timothy Patrick O'Rourke (CEO) | Bought (not open market) | — |
| May 7, 2026 | Timothy Patrick O'Rourke (CEO) | Bought (not open market) | — |
| Apr 15, 2026 | Benjamin Shaker (C-suite exec) | Sold (not open market) | $15.3K |
| Apr 15, 2026 | Girish Venkatachaliah (CTO) | Sold (not open market) | $8.9K |
| Apr 15, 2026 | Denise Zamore (C-suite exec) | Sold (not open market) | $5.9K |
| Apr 15, 2026 | Timothy Gertsch (C-suite exec) | Sold (not open market) | $3.3K |
| Apr 14, 2026 | Benjamin Shaker (C-suite exec) | Sold (not open market) | $2.4K |
| Apr 14, 2026 | Girish Venkatachaliah (CTO) | Sold (not open market) | $2.2K |
| Apr 14, 2026 | Timothy Gertsch (C-suite exec) | Sold (not open market) | $567 |
| Apr 14, 2026 | Denise Zamore (C-suite exec) | Sold (not open market) | $454 |
| Apr 1, 2026 | Benjamin Shaker (C-suite exec) | Sold (not open market) | $16.2K |
| Apr 1, 2026 | Jeffrey A. Schwaneke (CFO) | Sold (not open market) | $16.2K |
| Apr 1, 2026 | Denise Zamore (C-suite exec) | Sold (not open market) | $10K |
| Apr 1, 2026 | Girish Venkatachaliah (CTO) | Sold (not open market) | $4.7K |
Who's trading AGL
- Timothy Gertsch, C-suite exec: other filings, last Aug 16, 2026
- Denise Zamore, C-suite exec: bought $0 (1 buy), last Aug 1, 2026
- Jeffrey A. Schwaneke, CFO: other filings, last Jul 1, 2026
- Silvana Battaglia, Director: other filings, last Jun 2, 2026
- Diana McKenzie, Director: other filings, last Jun 2, 2026
- Sharad Mansukani, Director: other filings, last Jun 2, 2026
- Karen McLoughlin, Director: other filings, last Jun 2, 2026
- Ronald A Williams, Director: other filings, last Jun 2, 2026
- John William Wulf, Director: bought $50.9K (1 buy), last Jun 2, 2026
- Timothy Patrick O'Rourke, CEO: other filings, last May 7, 2026
- Benjamin Shaker, C-suite exec: bought $301K (2 buys), last Apr 15, 2026
- Girish Venkatachaliah, CTO: bought $0 (1 buy), last Apr 15, 2026
Get free alerts when an insider at agilon health, Inc files a new trade →